S&P rates MedImpact loans B+

S&P said it assigned a B+ issuer credit rating to MedImpact Holdings Inc.

At the same time, the agency assigned a B+ issue-level and 3 recovery rating to the proposed senior secured credit facility, which will be issued by subsidiary MI OpCo Holdings Inc. The 3 recovery rating indicates an expectation for meaningful recovery (50%-70%; rounded estimate: 65%) in the event of a payment default.

The outlook is stable.

S&P said MedImpact is refinancing its capital structure with a $550 million term loan B and a $650 million delayed-draw incremental term loan. S&P expects the company will use the delayed-draw term loan to fund near-term acquisition opportunities.

“The stable outlook reflects our expectation that MedImpact will generally maintain leverage between 3x and 4x as it pursues and integrates acquisitions,” S&P said in a news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.